Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...

Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi that the ...

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

In this article, we will take a look at the 12 stocks that will double in 2025.

In recognition of Change Your Password Day, Keeper Security, the leading cybersecurity provider of zero-trust and zero-knowledge Privileged Access Management (PAM) software protecting passwords, ...

As such, the tech giant is conducting a limited test of ads on Threads with a small number of advertisers, allowing them to extend their existing Meta ad campaigns to the app while the service ...